Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications

Por Trujillo, Toby, Dobesh, Paul P.
Publicado em 2014

New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Por Dobesh, Paul P., Fanikos, John
Publicado no Drugs (2014)

Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities

Por Dobesh, Paul P., Fanikos, John
Publicado no Drugs (2015)

Erratum to: Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications

Por Trujillo, Toby, Dobesh, Paul P.
Publicado no Drugs (2014)

Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation With Direct Oral Anticoagulants. Is One Of These Not Like The Others?

Por Dobesh, Paul P, Fanikos, John
Publicado no J Atr Fibrillation (2016)

The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease

Por Dobesh, Paul P., Patel, Manesh
Publicado no Cardiovasc Drugs Ther (2017)

Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety

Por Dobesh, Paul P, Oestreich, Julie H
Publicado no Pharmacotherapy (2014)

Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy

Por Finks, Shannon W., Trujillo, Toby C., Dobesh, Paul P.
Publicado no Ann Pharmacother (2016)

Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects

Por Dobesh, Paul P, Urban, Jamela F, Shurmur, Scott W, Oestreich, Julie H
Publicado no Thromb J (2015)

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism

Por Smythe, Maureen A., Priziola, Jennifer, Dobesh, Paul P., Wirth, Diane, Cuker, Adam, Wittkowsky, Ann K.
Publicado no J Thromb Thrombolysis (2016)